Editorial
Correspondence:
- 1.
- Meddling with drugs [editorial]. The Sydney Morning Herald 2000; 2 Dec.
- 2.
- Drugs scheme has its benefits [editorial]. Australian Financial Review 2000; 13 Dec.
- 3.
- The Auditor-General Audit Report No. 12, 1997-98: Peformance Audit -- Pharmaceutical Benefits Scheme, Department of Health and Family Services. <http://www.anao.gov.au> (accessed February 2001).
- 4.
- Cookson R. ASTEC non-EU case study on Australia. London: LSE Health, London School of Economics, 2000 <http://www.lse.ac.uk/Depts/lse_health/res_ projects/oz.pdf> (accessed February 2001)
- 5.
- Witcher SK. In the land down under, a model for national drug insurance. The Wall Street Journal 2000; 6 Sept.
- 6.
- M-TAG Pty Ltd. Report on the Australian System of Pharmaceutical Financing and Delivery. Vol 1: Efficiency and equity implications of public versus private funding of pharmaceuticals. Chatswood, NSW: Medical Technology Assessment Group, Nov 1999.
- 7.
- PBS expenditure and prescriptions. <www.health.gov.au/haf/docs/ pbbexp/index.htm> (accessed February 2001).
- 8.
- National Health Act (1953, amended 1987). <http://www.austlii.edu.au> (accessed February 2001).
- 9.
- Pfizer Pty Ltd v Birkett. Federal Court of Australia 20 March 2000. <http://www.fedcourt.gov.au/judgments/judgmts.html> (accessed February 2001).
- 10.
- Moynihan R. A dose of drama in debate on drugs. Australian Financial Review 2000; 8 Dec.
- 11.
- Angell M. The Pharmaceutical Industry -- to whom is it accountable? N Engl J Med 2000; 342: 1902-1904.
- 12.
- Mullins CD, Ogilvie S. Emerging standardization in pharmaco-economics. Clin Ther 1998; 20: 1194-1202.
- 13.
- Yamey G. NICE to rule on influenza flu drug zanamivir. BMJ 1999; 319: 937.
- 14.
- Harris G. Drug firms, stymied in the lab, become marketing machines. The Wall Street Journal 2000; 6 July.
- 15.
- le Carr J. The biggest pushers of all. The Spectator (London) 2000; 16 Dec.
- 16.
- Schoofs M. Glaxo attempts to block access to generic AIDS drugs in Ghana. The Wall Street Journal 2000; 1 Dec.
- 17.
- Gellman G. A turning point that left millions behind. Washington Post 2000; 28 Dec.
- 18.
- Korcok M. Cheap prescription drugs creating new brand of US tourist in Canada, Mexico. CMAJ 2000; 162: 1869-1870.
- 19.
- Silverman E. Drug makers on attack in Maine. The Star Ledger (New Jersey) 2000; 24 Sep.
- 20.
- Shuchman M. Drug company threatens legal action over Canadian guidelines. BMJ 1999; 319: 1388.
- 21.
- Nathan DG, Weatherall DJ. Academia and industry: lessons from the unfortunate events in Toronto. Lancet 1999; 353: 771-772.
- 22.
- Rennie D. Thyroid storm. JAMA 1997; 277: 1238-1243.
- 23.
- Dyer C. Viagra guidance declared unlawful. BMJ 1999; 318: 1509.
- 24.
- McNeil DG. Drug companies and the Third World: a case study in neglect. The New York Times; 2000: 21 May.
- 25.
- Silverstein K. Millions for Viagra. Pennies for the poor. The Toronto Star 1999; 13 Aug.
- 26.
- Mansfield P. Sickening sales pitch of the drug marketers. The Sydney Morning Herald 2000; 3 July.
- 27.
- Department of Health and Aged Care. Pharmaceutical Benefits Branch. <http://www.health.gov.au/haf/docs/pbacrec.htm> (accessed February 2001).
- 28.
- Angell M. Is academic medicine for sale? N Engl J Med 2000; 342: 1516-1518.
Online responses are no longer available. Please refer to our instructions for authors page for more information.